Cytochrome P450 Oxidoreductase Gene Mutations and Antley-Bixler Syndrome with Abnormal Genitalia and/or Impaired Steroidogenesis: Molecular and Clinical Studies in 10 Patients
The DOI matches its Crossref record; 47 of the 50 references it cites were found in a registry or an index.
Abstract
We report on molecular and clinical findings in 10 Japanese patients (four males and six females) from eight families (two pairs of siblings and six isolated cases) with Antley-Bixler syndrome accompanied by abnormal genitalia and/or impaired steroidogenesis. Direct sequencing was performed for all the 15 exons of cytochrome P450 oxidoreductase gene (POR), showing two missense mutations (R457H and Y578C), a 24-bp deletion mutation resulting in loss of nine amino acids and creation of one amino acid (L612_W620delinsR), a single bp insertion mutation leading to frameshift (I444fsX449), and a silent mutation (G5G). R457H has previously been shown to be a pathologic mutation, and computerized modeling analyses indicated that the 15A>G for G5G could disturb an exonic splicing enhancer motif, and the remaining three mutations should affect protein conformations. Six patients were compound heterozygotes, and three patients were R457H homozygotes; no mutation was identified on one allele of the remaining one patient. Clinical findings included various degrees of skeletal features, such as brachycephaly, radiohumeral synostosis, and digital joint contractures in patients of both sexes, normal-to-poor masculinization during fetal and pubertal periods in male patients, virilization during fetal life and poor pubertal development without worsening of virilization in female patients, and relatively large height gain and delayed bone age from the pubertal period in patients of both sexes, together with maternal virilization during pregnancy. Blood cholesterol was grossly normal, and endocrine studies revealed defective CYP17A1 and CYP21A2 activities. The results suggest that Antley-Bixler syndrome with abnormal genitalia and/or impaired steroidogenesis is caused by POR mutations, and that clinical features are variable and primarily explained by impaired activities of POR-dependent CYP51A1, CYP17A1, CYP21A2, and CYP19A1.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“When ABS is seen in association with abnormal steroids and ambiguous genitalia in either sex, the cause is an autosomal recessive mutation in POR (305, 314 -317);”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [317]
In the citing paper
“Despite its embryonic lethality in mice, POR deficiency is a newly recognized form of CAH (305, 314 -319).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [317]
In the citing paper
“This is the usual outcome among infants carrying the R457H mutation (prevalent in Japan), but not with the A287P mutation (prevalent in Europe)”
From Steroidogenic electron-transfer factors and their diseases (2021) · cites this paper as [66]
In the citing paper
“Most patients with POR deficiency have normal electrolytes and normal basal cortisol concentrations that respond poorly to ACTH, indicating compensated adrenal insufficiency”
From Steroidogenic electron-transfer factors and their diseases (2021) · cites this paper as [66]
Citations
Cites
Williams Textbook of Endocrinology
(2016) · Elsevier eBooks · doi:10.1016/c2013-0-15980-6 · Cited by 3,711
Listening to silence and understanding nonsense: exonic mutations that affect splicing
Cartegni, L., Chew, S. L., & Krainer, A. R. (2002) · Nature Reviews Genetics · doi:10.1038/nrg775 · Cited by 2,209 · cited 2×
“Indeed, it has been shown that silent, as well as nonsense and missense, mutations can affect the splicing mechanism (16).”
BackgroundESEfinder: a web resource to identify exonic splicing enhancers
Cartegni, L. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg616 · Cited by 1,603
Napoli, C., D'Armiento, F. P., Mancini, F. P., Postiglione, A., Witztum, J. L., Palumbo, G., & Palinski, W. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119813 · Cited by 1,014 · cited 1×
“Because fetal blood cholesterol value correlates with maternal blood cholesterol value (37), a relatively large amount of cholesterol might have been transported into the developing skeletal tissues via LDL receptor with a low normal activity, as well as via other pathways (34), mitigating the skeletal features of cas…”
BackgroundMurray, R. K. (1998) · Medical Entomology and Zoology · Cited by 905
Wang, M., Roberts, D. L., Paschke, R., Shea, T. M., Masters, B. S. S., & Kim, J.-J. P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8411 · Cited by 744 · cited 1×
“Because the R457 residue plays an essential role in the FAD binding and stabilization (10, 14), R457H may specifically disturb the interaction with FAD in the absence of a gross conformational alteration.”
BackgroundESyPred3D: Prediction of proteins 3D structures
Lambert, C., Léonard, N., De Bolle, X., & Depiereux, E. (2002) · Bioinformatics · doi:10.1093/bioinformatics/18.9.1250 · Cited by 611
Steroidogenic enzymes: Structure, function, and role in regulation of steroid hormone biosynthesis
Hanukoglu, I. (1992) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(92)90307-5 · Cited by 554 · cited 2×
“In addition, because CYP19A1 (aromatase) activity should also be impaired in POR mutations (9), this would affect pubertal estrogen production.”
BackgroundMutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome
Flück, C. E., Tajima, T., Pandey, A. V., Arlt, W., Okuhara, K., Verge, C. F., Jabs, E. W., Mendonça, B. B., Fujieda, K., & Miller, W. L. (2004) · Nature Genetics · doi:10.1038/ng1300 · Cited by 509
Disorders of sex differentiation
Grumbach, M. M. (1992) · Medical Entomology and Zoology · Cited by 402
Cited by
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458
Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management
Claahsen - van der Grinten, H. L., Speiser, P. W., Ahmed, S. F., Arlt, W., Auchus, R. J., Falhammar, H., Flück, C. E., Guasti, L., Huebner, A., Kortmann, B. B. M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab016 · Cited by 556
Malformation syndromes caused by disorders of cholesterol synthesis
Porter, F. D., & Herman, G. E. (2011) · Journal of Lipid Research · doi:10.1194/jlr.r009548 · Cited by 473
Steroidogenesis in the Fetal Testis and Its Susceptibility to Disruption by Exogenous Compounds
Scott, H. M., Mason, J. I., & Sharpe, R. M. (2009) · Endocrine Reviews · doi:10.1210/er.2009-0016 · Cited by 350
“CYP19 activity are virilized (210); and 2) PORD also causes a reduction in the supply of DHEA, the precursor for both androstenedione and testosterone (209, 211).”
BackgroundHuang, N., Pandey, A. V., Agrawal, V., Reardon, W., Lapunzina, P. D., Mowat, D., Jabs, E. W., Vliet, G. V., Sack, J., Flück, C. E., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/429417 · Cited by 336
“R457H was also found on 1 of 2 Jap- Huang et al.: P450 Oxidoreductase Deficiency 739 anese alleles in our initial study (Flück et al. 2004) and on 2 of 4 alleles (Adachi et al. 2004) and 10 of 16 alleles (Fukami et al. 2005) in two recent studies of Japanese patients.”
BackgroundMinireview: Regulation of Steroidogenesis by Electron Transfer
Miller, W. L. (2005) · Endocrinology · doi:10.1210/en.2005-0096 · Cited by 324
Genetics of congenital adrenal hyperplasia
Krone, N., & Arlt, W. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.10.014 · Cited by 312
NADPH P450 oxidoreductase: Structure, function, and pathology of diseases
Pandey, A. V., & Flück, C. E. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.010 · Cited by 279
Flück, C. E., Meyer-Böni, M., Pandey, A. V., Kempná, P., Miller, W. L., Schoenle, E. J., & Biason-Lauber, A. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.06.009 · Cited by 248
Huang, N., Agrawal, V., Giacomini, K. M., & Miller, W. L. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711621105 · Cited by 198
“For example, the rare silent exon 1 SNP 15A3G, which may be associated with altered POR RNA splicing (28), seems to confer a modestly increased risk for breast cancer in African-American women (16).”
BackgroundLorbek, G., Lewinska, M., & Rozman, D. (2012) · The FEBS Journal · doi:10.1111/j.1742-4658.2011.08432.x · Cited by 196
Highly sensitive analysis of sterol profiles in human serum by LC-ESI-MS/MS
Honda, A., Yamashita, K., Miyazaki, H., Shirai, M., Ikegami, T., Xu, G., Numazawa, M., Hara, T., & Matsuzaki, Y. (2008) · Journal of Lipid Research · doi:10.1194/jlr.d800017-jlr200 · Cited by 164
Genotype-Phenotype Analysis in Congenital Adrenal Hyperplasia due to P450 Oxidoreductase Deficiency
Krone, N., Reisch, N., Idkowiak, J., Dhir, V., Ivison, H. E., Hughes, B. A., Rose, I. T., O'Neil, D. M., Vijzelaar, R., Smith, M. J., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0640 · Cited by 163
Homma, K., Hasegawa, T., Nagai, T., Adachi, M., Horikawa, R., Fujiwara, I., Tajima, T., Takeda, R., Fukami, M., & Ogata, T. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2460 · Cited by 153
Self-citationGuengerich, F. P. (2015) · Springer eBooks · doi:10.1007/978-3-319-12108-6_9 · Cited by 214
MECHANISMS IN ENDOCRINOLOGY: Rare defects in adrenal steroidogenesis
Miller, W. L. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0279 · Cited by 136
Modulation of human CYP19A1 activity by mutant NADPH P450 oxidoreductase
Pandey, A. V., Kempná, P., Hofer, G., Mullis, P. E., & Flück, C. E. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0245 · Cited by 132
Congenital adrenal hyperplasia and P450 oxidoreductase deficiency
Krone, N., Dhir, V., Ivison, H. E., & Arlt, W. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02740.x · Cited by 131
Understanding the genetic aetiology in patients with XY DSD
Ahmed, S. F., Bashamboo, A., Lucas-Herald, A. K., & McElreavey, K. (2013) · British Medical Bulletin · doi:10.1093/bmb/ldt008 · Cited by 145
NADPH–cytochrome P450 oxidoreductase: Prototypic member of the diflavin reductase family
Iyanagi, T., Xia, C., & Kim, J.-J. P. (2012) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2012.09.002 · Cited by 117
Fukami, M., Nishimura, G., Homma, K., Nagai, T., Hanaki, K., Uematsu, A., Ishii, T., Numakura, C., Sawada, H., Nakacho, M., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2816 · Cited by 117
“8 yr (16 patients with 46,XY and 19 patients with 46,XX), including previously reported 23 cases (6, 8, 9) (Table 1).”
BackgroundInfluentialSelf-citationAgrawal, V., Huang, N., & Miller, W. L. (2008) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32830054ac · Cited by 117
Genetic and clinical features of P450 oxidoreductase deficiency
Scott, R. R., & Miller, W. L. (2008) · Hormone Research in Paediatrics · doi:10.1159/000114857 · Cited by 115
Fukami, M., Homma, K., Hasegawa, T., & Ogata, T. (2013) · Developmental Dynamics · doi:10.1002/dvdy.23892 · Cited by 114
“Because worsening of virilization has not been observed in genetic female patients with PORD after birth (Fukami et al., 2005), such a mechanism appears to take place primarily during the fetal life.”
BackgroundSelf-citationIsolated 17,20-lyase deficiency due to the cytochrome b5 mutation W27X
Kok, R. C., Timmerman, M. A., Wolffenbuttel, K. P., Drop, S. L. S., & de Jong, F. H. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1745 · Cited by 111
“A final point distinguishing the findings in our patient from those in patients with POR or CYP17A1 mutations is the observation that in these patients cortisol levels do not increase after ACTH stimulation (11, 22), whereas in the present patient both basal and ACTH-stimulated cortisol levels were completely normal.”
BackgroundKeber, R., Motaln, H., Wagner, K. D., Debeljak, N., Rassoulzadegan, M., Ačimovič, J., Rozman, D., & Horvat, S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.253245 · Cited by 102
Hart, S. N., Wang, S., Nakamoto, K., Wesselman, C., Li, Y., & Zhong, X.-B. (2008) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3282f2f121 · Cited by 98
Genetics of Congenital Adrenal Hyperplasia
Hannah-Shmouni, F., Chen, W., & Merke, D. P. (2017) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2017.01.008 · Cited by 97
Recent insights into the Smith–Lemli–Opitz syndrome
Yu, H., & Patel, S. (2005) · Clinical Genetics · doi:10.1111/j.1399-0004.2005.00515.x · Cited by 97
“However, a recent large survey of patients with ABS shows that individuals with an ABS-like phenotype and normal steroidogenesis have fibroblast growth factor receptor (FGFR) mutations, whereas those with ambiguous genitalia are caused by genetic defects of P450 oxidoreductase (POR), which is responsible for steroidog…”
BackgroundHershkovitz, E., Parvari, R., Wudy, S. A., Hartmann, M. F., Gomes, L. G., Loewental, N., & Miller, W. L. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0051 · Cited by 95
“None of our patients has had adrenal insufficiency, but adrenal crisis has been reported in some cases of POR deficiency (18).”
BackgroundConsequences of POR mutations and polymorphisms
Miller, W. L., Agrawal, V., Sandee, D., Tee, M. K., Huang, N., Choi, J. H., Morrissey, K., & Giacomini, K. M. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.10.022 · Cited by 88
“…ambiguous genitalia in either sex, the cause is an autosomal recessive mutation in POR (Adachi et al., 2004; Arlt et al., 2004; Fluck et al., 2004; Fukami et al., 2005; Hershkovitz et al., 2008; Huang et al., 2005; Sahakitrungruang et al., 2009; Scott and Miller, 2008); by contrast, when ABS is…”
BackgroundInfluentialClinical, genetic and enzymatic characterization of P450 oxidoreductase deficiency in four patients
Sahakitrungruang, T., Huang, N., Tee, M. K., Agrawal, V., Russell, W. E., Crock, P., Murphy, N., Migeon, C. J., & Miller, W. L. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1460 · Cited by 82
Fukami, M., Hasegawa, T., Horikawa, R., Ohashi, T., Nishimura, G., Homma, K., & Ogata, T. (2006) · Pediatric Research · doi:10.1203/01.pdr.0000195825.31504.28 · Cited by 79
“This is consistent with R457H being the most frequent mutation in the Japanese patients (4).”
BackgroundMethodResultSelf-citationP450 Oxidoreductase deficiency: Analysis of mutations and polymorphisms
Burkhard, F. Z., Parween, S., Udhane, S. S., Flück, C. E., & Pandey, A. V. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.04.003 · Cited by 79
Scott, R. R., Gomes, L. G., Huang, N., Van Vliet, G., & Miller, W. L. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2345 · Cited by 79
Differential Inhibition of CYP17A1 and CYP21A2 Activities by the P450 Oxidoreductase Mutant A287P
Dhir, V., Ivison, H. E., Krone, N., Shackleton, C. H. L., Doherty, A. J., Stewart, P. M., & Arlt, W. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0066 · Cited by 78
Tomalik-Scharte, D., Maiter, D., Kirchheiner, J., Ivison, H. E., Fuhr, U., & Arlt, W. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0764 · Cited by 77
Effects of genetic variants of human P450 oxidoreductase on catalysis by CYP2D6 in vitro
Sandee, D., Morrissey, K., Agrawal, V., Tam, H. K., Kramer, M. A., Tracy, T. S., Giacomini, K. M., & Miller, W. L. (2010) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32833f4f9b · Cited by 74
Horvat, S., Mcwhir, J., & Rozman, D. (2011) · Drug Metabolism Reviews · doi:10.3109/03602532.2010.540580 · Cited by 67
“Mutations in the POR gene explained not only some phenotypes of ABS, but also the combined partial impairment of the steroidogenic enzymes, 17-hydroxylase and 21-hydroxylase, where affected patients show evidence of impaired steroid synthesis (Fukami et al., 2005, 2006).”
BackgroundIdkowiak, J., O'Riordan, S., Reisch, N., Malunowicz, E. M., Collins, F., Kerstens, M. N., Köhler, B., Graul-Neumann, L. M., Szarras-Czapnik, M., Dattani, M., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1607 · Cited by 64
“This is a common finding in females affected by steroidogenic disorders and has been reported in 21-hydroxylase deficiency (18, 19), 17 -hydroxylase deficiency (20–22), congenital lipoid adrenal hyperplasia due to mutant steroidogenic acute regulatory protein (23–25), P450 aromatase deficiency (26, 27), and also recen…”
Sheng, L., Ding, X., Ferguson, M., McCallister, M., Rhoades, R., Maguire, M., Ramesh, A., Aschner, M., Campbell, D., Levitt, P., et al. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq304 · Cited by 63
“…have already been identified including the Cpr-low mouse that exhibits a degree of infertility and altered steroid homeostasis (Wu et al., 2007) are known to occur at appreciable frequencies in human patients (Arlt et al., 2004; Fluck et al., 2004; Fukami et al., 2005, 2006; Huang et al., 2005).”
BackgroundLiu, Y., Wang, L., Yang, Y., Liang, Y., Zhang, T.-J., Liang, N., Yang, L., Li, S.-J., Shan, D., & Wu, Q. (2019) · Diagnostic Pathology · doi:10.1186/s13000-019-0853-x · Cited by 65
P450 oxidoreductase: genetic polymorphisms and implications for drug metabolism and toxicity
Hart, S. N., & Zhong, X.-B. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.4.4.439 · Cited by 70
“More data on polymorphisms in the general population are necessary to identify relevant polymorphisms, such as L577P, that are associated with decreased drug metabolism in individuals without POR deficiency.”
BackgroundInfluentialElectron Transfer Partners of Cytochrome P450
Waskell, L. A., & Kim, J. P. (2015) · Springer eBooks · doi:10.1007/978-3-319-12108-6_2 · Cited by 87
“Mutations in human POR that significantly disrupt cholesterol biosynthesis and/or steroidogenesis have been shown to result in POR deficiency, characterized by Antley–Bixler syndrome and disordered steroidogenesis [108, 114].”
BackgroundSchmidt, K., Hughes, C., Chudek, J. A., Goodyear, S. R., Aspden, R. M., Talbot, R., Gundersen, T. E., Blomhoff, R., Henderson, C., Wolf, C. R., et al. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01638-08 · Cited by 61
“Furthermore, some patients with POR mutations have defects in the limb skeleton (29).”
BackgroundCongenital adrenal hyperplasia: focus on the molecular basis of 21-hydroxylase deficiency
Gonçalves, J., Friães, A., & Moura, L. (2007) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399407000300 · Cited by 60
Flück, C. E., Mullis, P. E., & Pandey, A. V. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.09.035 · Cited by 59
Baronio, F., Ortolano, R., Menabò, S., Cassio, A., Baldazzi, L., Natale, V. D., Tonti, G., Vestrucci, B., & Balsamo, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184605 · Cited by 60
Marohnic, C. C., Panda, S. P., Martásek, P., & Masters, B. S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m607095200 · Cited by 57
P450 oxidoreductase deficiency: a new form of congenital adrenal hyperplasia
Flück, C. E., & Miller, W. L. (2006) · Current Opinion in Pediatrics · doi:10.1097/01.mop.0000236395.71956.5c · Cited by 57
Flück, C. E., Nicolo, C., & Pandey, A. V. (2007) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.2007.00520.x · Cited by 55
Molecular Basis of Adrenal Insufficiency
Fujieda, K., & Tajima, T. (2005) · Pediatric Research · doi:10.1203/01.pdr.0000159568.31749.4d · Cited by 51
“Thus, partial deficiency of these P450 enzymes caused by the mutation of POR may be responsible for the various clinical phenotypes of ABS with adrenal insufficiency (14,15).”
BackgroundThe Adrenal Cortex and its Disorders
Miller, W. L. (2009) · Brook's Clinical Pediatric Endocrinology · doi:10.1002/9781444316728.ch13 · Cited by 50
Clinical and Biochemical Consequences of P450 Oxidoreductase Deficiency
Flück, C. E., & Pandey, A. V. (2011) · Endocrine Development · doi:10.1159/000321221 · Cited by 52
Kranendonk, M., Marohnic, C. C., Panda, S. P., Duarte, M. P., Oliveira, J. S., Masters, B. S. S., & Rueff, J. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.04.014 · Cited by 60
Marohnic, C. C., Panda, S. P., McCammon, K. M., Rueff, J., Masters, B. S. S., & Kranendonk, M. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.030445 · Cited by 58
Restoration of mutant cytochrome P450 reductase activity by external flavin
Nicolo, C., Flück, C. E., Mullis, P. E., & Pandey, A. V. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.02.024 · Cited by 50
Tee, M. K., Huang, N., Damm, I., & Miller, W. L. (2011) · Molecular Endocrinology · doi:10.1210/me.2010-0236 · Cited by 46
Dean, B., Chrisp, G. L., Quartararo, M., Maguire, A. M., Hameed, S., King, B. R., Munns, C. F., Torpy, D. J., Falhammar, H., & Rushworth, R. L. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz255 · Cited by 43
“Of the 90 unique patients in the cohort, 42 were collected from four larger studies (5,7,16,18), while”
BackgroundAdrenal cortex and its disorders
Miller, W. L., & Flück, C. E. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-4858-7.00022-6 · Cited by 60
Spectrum of Antley-Bixler Syndrome
McGlaughlin, K. L., Witherow, H., Dunaway, D. J., David, D. J., & Anderson, P. J. (2010) · Journal of Craniofacial Surgery · doi:10.1097/scs.0b013e3181ec6afe · Cited by 41
Impact on CYP19A1 activity by mutations in NADPH cytochrome P450 oxidoreductase
Flück, C. E., & Pandey, A. V. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.03.031 · Cited by 43
Udhane, S. S., Parween, S., Kagawa, N., & Pandey, A. V. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00580 · Cited by 38
“Afterward, many other laboratories reported mutations in POR in patients with steroidogenic disorders and/or bone malformation syndromes (Adachi et al., 2004; Arlt et al., 2004; Fukami et al., 2005; Pandey and Flück, 2013; Riddick et al., 2013).”
BackgroundYazawa, T., Imamichi, Y., Sekiguchi, T., Miyamoto, K., Uwada, J., Khan, M. R. I., Suzuki, N., Umezawa, A., & Taniguchi, T. (2019) · BioMed Research International · doi:10.1155/2019/8973076 · Cited by 44
Parween, S., Roucher-Boulez, F., Flück, C. E., Lienhardt-Roussie, A., Mallet, D., Morel, Y., & Pandey, A. V. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1928 · Cited by 37
“02 (13) CYP17A1: lyase activity (17-OHPreg to DHEA) WT 40.”
BackgroundPandey, A. V., Flück, C. E., & Mullis, P. E. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.08.072 · Cited by 36
Update on Adrenarche—Still a Mystery
Augsburger, P., Liimatta, J., & Flück, C. E. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae008 · Cited by 48
Translating genomics to the clinical diagnosis of disorders/differences of sex development
Parivesh, A., Barseghyan, H., Délot, E. C., & Vilain, E. J. N. (2019) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2019.01.005 · Cited by 39
Bai, Y., Li, J., & Wang, X. (2017) · Journal of Ovarian Research · doi:10.1186/s13048-017-0312-9 · Cited by 34
“Most of the reported patients are of Japanese or European descent (38:46).”
InfluentialLi, H., Zhao, A., Xie, M., Chen, L., Wu, H., Shen, Y., & Wang, H. (2021) · Translational Pediatrics · doi:10.21037/tp-21-499 · Cited by 36
“7%), which is the same founder mutation identified in Japanese patients (11,15,20).”
BackgroundJanner, M., Flück, C. E., & Mullis, P. E. (2012) · Hormone Research in Paediatrics · doi:10.1159/000341585 · Cited by 36
POR R457H is a global founder mutation causing Antley–Bixler syndrome with autosomal recessive trait
Adachi, M., Asakura, Y., Matsuo, M., Yamamoto, T., Hanaki, K., & Arlt, W. (2006) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31112 · Cited by 34
McCammon, K. M., Panda, S. P., Xia, C., Kim, J.-J. P., Moutinho, D., Kranendonk, M., Auchus, R. J., Lafer, E. M., Ghosh, D., Martasek, P., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.716019 · Cited by 33
Cytochrome P450 Oxidoreductase Deficiency
Idkowiak, J., Cragun, D. L., Hopkin, R. J., & Arlt, W. (2009) · University of Washington, Seattle eBooks · Cited by 33
Dobrinas, M., Cornuz, J., Pedrido, L., & Eap, C. B. (2012) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32834e9e1a · Cited by 32
Papadakis, G. E., Dumont, A., Bouligand, J., Chasseloup, F., Raggi, A., Catteau-Jonard, S., Boute‐Bénéjean, O., Pitteloud, N., Young, J., & Dewailly, D. (2020) · Human Reproduction · doi:10.1093/humrep/deaa020 · Cited by 38
Nomenclature for alleles of the cytochrome P450 oxidoreductase gene
Sim, S. C., Miller, W. L., Zhong, X.-B., Arlt, W., Ogata, T., Ding, X., Roland Wolf, C., Flück, C. E., Pandey, A. V., Henderson, C. J., et al. (2009) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32832af5b7 · Cited by 31
“Among the more important POR variants are POR*2 and *5 (Arg457His and Ala287Pro, respectively), the former being the most frequent mutation in Japanese and Chinese POR-deficient patients [5,15], whereas the latter is the POR mutation most frequently found in Caucasians.”
BackgroundSelf-citationMoutinho, D., Marohnic, C. C., Panda, S. P., Rueff, J., Masters, B. S. S., & Kranendonk, M. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.042820 · Cited by 38
P450 oxidoreductase deficiency and Antley–Bixler syndrome
Arlt, W. (2007) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-007-9056-y · Cited by 36
Classic and backdoor pathways of androgen biosynthesis in human sexual development
Lee, H. G., & Kim, C. J. (2022) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2244124.062 · Cited by 42
Koyama, Y., Homma, K., Fukami, M., Miwa, M., Ikeda, K., Ogata, T., Hasegawa, T., & Murata, M. (2012) · Clinical Chemistry · doi:10.1373/clinchem.2011.173286 · Cited by 30
Self-citationP450 Oxidoreductase Deficiency: A New Disorder of Steroidogenesis
Miller, W. L., Huang, N., Pandey, A. V., Flück, C. E., & Agrawal, V. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1336.012 · Cited by 37
Williamson, L., Arlt, W., Shackleton, C., Kelley, R. I., & Braddock, S. R. (2006) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31385 · Cited by 30
“The findings in this patient embody the biochemical and molecular findings supporting other cases in the literature [Arlt et al., 2004; Fluck et al., 2004; Wudy et al., 2004; Adachi et al., 2004b; Shackleton et al., 2004b; Fukami et al., 2005; Huang et al., 2005].”
BackgroundResultInfluentialLi, Z., Chadalapaka, G., Ramesh, A., Khoshbouei, H., Maguire, M., Safe, S., Rhoades, R. E., Clark, R., Jules, G., McCallister, M., et al. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfr261 · Cited by 29
“Interestingly, additional phenotypes of the Cpr-low mouse have already been identified such as female infertility and an altered steroid homeostasis known to occur in human subjects (Artl et al., 2004; Fluck et al., 2004; Fukami et al., 2005, 2006; Huang et al., 2005).”
BackgroundKo, J. M., Cheon, C.-K., Kim, G.-H., & Yoo, H.-W. (2009) · European Journal of Pediatrics · doi:10.1007/s00431-008-0849-0 · Cited by 28
“That is why glucocorticoid supplementation therapy is recommended to avoid adrenal crisis, particularly during stressful situations [2, 8, 9 ].”
BackgroundThe Adrenal Cortex and Its Disorders
Miller, W. L., Achermann, J. C., & Flück, C. E. (2008) · Elsevier eBooks · doi:10.1016/b978-141604090-3.50017-x · Cited by 33
Parween, S., Fernández-Cancio, M., Benito-Sanz, S., Camats, N., Rojas Velazquez, M. N., López-Siguero, J.-P., Udhane, S. S., Kagawa, N., Flück, C. E., Audí, L., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa076 · Cited by 28
Saito, Y., Yamamoto, N., Katori, N., Maekawa, K., Fukushima‐Uesaka, H., Sugimoto, D., Kurose, K., Sai, K., Kaniwa, N., Sawada, J.-I., et al. (2010) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.dmpk-10-sc-096 · Cited by 27
Parween, S., Velazquez, M. N. R., Udhane, S. S., Kagawa, N., & Pandey, A. V. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01187 · Cited by 24
“Several variants in the POR gene found in patients as well as nonclinical samples have been tested for enzymatic activities (Adachi et al., 2004; Arlt et al., 2004; Fukami et al., 2005; Fukami et al., 2006; Homma et al., 2006; Pandey, 2006; Huang et al., 2008a; Sim et al., 2009).”
BackgroundRoles of retinoic acid signaling in normal and abnormal development of the palate and tongue
Okano, J., Udagawa, J., & Shiota, K. (2014) · Congenital Anomalies · doi:10.1111/cga.12049 · Cited by 30
“So far, two causative genes have been identified: electron donor enzyme P450 oxidoreductase (POR) and fibroblast growth factor receptor 2 (FGFR2) (Chun et al. 1998; Fluck et al. 2004; Fukami et al. 2005; Huang et al. 2005).”
BackgroundSteroidogenic electron-transfer factors and their diseases
Miller, W. L. (2021) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2142154.077 · Cited by 24
Mendoza‐Londono, R., Lammer, E. J., Watson, R., Harper, J. I., Hatamochi, A., Hatamochi-Hayashi, S., Napierala, D., Hermanns, P., Collins, S., Roa, B. B., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/431654 · Cited by 26
“Although the etiology of these syndromes has not been completely elucidated, some patients with Antley-Bixler syndrome carry mutations in the P450 oxidoreductase gene (POR [MIM 124015]) that result in abnormal steroidogenesis (Adachi et al. 2004; Fukami et al. 2005).”
BackgroundRare forms of congenital adrenal hyperplasia
Tosun, B. G., & Güran, T. (2023) · Clinical Endocrinology · doi:10.1111/cen.15009 · Cited by 28
Marohnic, C. C., Huber, W. J., Connick, J. P., Reed, J. R., McCammon, K. M., Panda, S. P., Martasek, P., Backes, W. L., & Masters, B. S. S. (2011) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2011.06.008 · Cited by 27
Haiman, C. A., Setiawan, V. W., Xia, L. Y., Marchand, L. L., Ingles, S. A., Ursin, G., Press, M. F., Bernstein, L., John, E. M., & Henderson, B. E. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4801 · Cited by 22
“It has been speculated that this SNP disrupts an exonic splicing enhancer motif in exon 1 of the POR gene, which could have an effect on the efficiency of premRNA splicing (5) and on regulating the activity of cytochrome P450 enzymes involved in steroid hormone biosynthesis.”
BackgroundAguilar, A., Wu, S., & De Luca, F. (2009) · Endocrinology · doi:10.1210/en.2009-0043 · Cited by 21
CYP51A1 in health and disease: from sterol metabolism to regulated cell death
Chen, F., Liang, R., Zhang, J., Kang, R., Tang, D., & Liu, J. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02621-7 · Cited by 27
“Indeed, ABS is associated with impaired aberrant steroidogenesis, which is largely attributed to impaired POR-dependent CYP51A1, CYP17A1, CYP21A2, and CYP19A1 activities [86].”
But, W. M., Lo, I. F. M., Shek, C., Tse, W. Y., & Lam, S. T. S. (2010) · PubMed · Cited by 22
Novel SNPs in Cytochrome P450 Oxidoreductase
Hart, S. N., Li, Y., Nakamoto, K., Wesselman, C., & Zhong, X. (2007) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.22.322 · Cited by 20
Guaragna-Filho, G., Castro, C. C. T. D. S., De Carvalho, R. R., Coeli, F. B., Ferraz, L. F. C., Petroli, R. J., De Mello, M. P., Sewaybricker, L. E., Lemos-Marini, S. H. V., D'Souza-Li, L. F. R., et al. (2012) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302012000800020 · Cited by 18
Metadata
- Authors
- Fukami, M., Horikawa, R., Nagai, T., Tanaka, T., Naiki, Y., Sato, N., Okuyama, T., Nakai, H., Soneda, S., Tachibana, K., Matsuo, N., Sato, S., Homma, K., Nishimura, G., Hasegawa, T., & Ogata, T.
- Affiliations
- National Research Institute for Child Health and Development (JP)
- National Center For Child Health and Development (JP)
- Departments of Pediatrics (T.N.)
- Departments of Pediatrics (N.M., S.Sa., T.H.), Tokyo 160-8582
- Dokkyo University (JP)
- St. Marianna University School of Medicine (JP)
- Kanagawa Children's Medical Center (JP)
- Keio University (JP)
- Tokyo Metropolitan Kiyose Children's Hospital (JP)
- Corresponding author
- Ogata, Tsutomu
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2005-01-01
- Volume
- 90
- Issue
- 1
- Pages
- 414-426
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2155186140
- Semantic Scholar
- 62a7c97b70b8a9cc00b8610a881abb5daade54fe
- Cited by
- 155
- References
- 50
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 3 · 2023: 7 · 2022: 5 · 2021: 5 · 2020: 7 · 2019: 7 · 2018: 4 · 2017: 4 · 2016: 7 · 2015: 2 · 2014: 2 · 2013: 5 · 2012: 8
- FWCI
- 4.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- Antley-Bixler syndrome, cytochrome P450 oxidoreductase, synonymous mutations, compound heterozygosity, exonic splicing enhancers, CYP17A1, CYP21A2, CYP51A1, CYP19A1, skeletal dysplasia, masculinization, delayed bone age, Japanese patients
- MeSH terms
- Abnormalities, Multiple, Adolescent, Adult, Bone and Bones, Child, Child, Preschool, Cholesterol, Cytochrome P-450 Enzyme System, Female, Genitalia, Growth, Humans, Male, Mutation, Steroids, Syndrome, Polymorphism, Single Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.